Procainamide: Clinical Trials

13 trials of Procainamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 terminated, 2 unknown, 1 withdrawn. 5 Phase 3, 5 Phase 4, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 35Completed 4, Terminated 1
Phase 45Completed 2, Terminated 2, Unknown 1
Not applicable2Completed 1, Withdrawn 1

Follow Procainamide: new trials by email Literature Review of Procainamide trials Research Report on Procainamide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Post-Operative Cardiac Arrhythmias
Dexmedetomidine, Magnesium Sulfate, Amiodarone - Cardiac; Dysrhythmia, Postoperative, Congenital Heart Surgery
Phase 4UnknownJeffrey Moak8702023-01-012022-03-15
RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department
Vernakalant, Procainamide - Atrial Fibrillation
Phase 4CompletedOttawa Hospital Research Institute3502021-06-172025-04-10
Management of Supraventricular Tachycardia of Children
adenosine,Propranolol,flecainide, amiodarone, propranolol, digoxin and procainamide. - Supraventricular Tachycardia
UnknownAssiut University502018-05-152018-05-18
Acute Mechanical Response to Anti-arrhythmic Drug Therapy
Procainamide - Arrhythmias
Not applicableWithdrawnEvan Adelstein, MD2015-10-012018-06-28
Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention
Antiarrhythmic Drug Therapy, Catheter ablation - Ventricular Tachycardia, Ventricular Arrhythmia
Phase 4TerminatedOttawa Heart Institute Research Corporation32014-10-012026-05-04
Chemical vs Electrical Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation
Electrical-first, Chemical-first - Atrial Fibrillation
Phase 3CompletedUniversity of British Columbia862013-11-012015-06-11
ST-segment Elevation as an AF Endophenotype
Procainamide - Atrial Fibrillation
Not applicableCompletedVanderbilt University Medical Center1612010-11-012018-05-02
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
flecainide, ajmaline, procainamide - Atrial Fibrillation, Tachycardia, Ventricular
Phase 4CompletedHospital Clinic of Barcelona1232008-06-012010-12-15
AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study
FDA approved rate and rhythm control drugs, AV Node ablation and device implant - Atrial Fibrillation, Heart Failure
Phase 3TerminatedMayo Clinic272007-12-012013-04-04
Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular Tachycardia
iv Amiodarone, iv Procainamide - Ventricular Tachycardia, Wide QRS Tachycardia
Phase 4TerminatedHospital General Universitario Gregorio Marañon3022005-09-012016-04-06
Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)
amiodarone, sotalol, propafenone - Arrhythmia, Atrial Fibrillation
Phase 3CompletedNational Heart, Lung, and Blood Institute (NHLBI)1995-03-012016-03-25
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
amiodarone, imipramine, mexiletine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Washington1987-04-012013-07-29
Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)
electrophysiology, electrocardiography, ambulatory, imipramine - Arrhythmia, Cardiovascular Diseases
Phase 3CompletedUniversity of Utah1985-07-012016-01-21

Conditions studied

Atrial Fibrillation (6)  ·  Arrhythmias, Cardiac (5)  ·  Tachycardia, Ventricular (4)  ·  Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Ventricular Fibrillation (2)  ·  Brugada Syndrome (1)  ·  Death, Sudden, Cardiac (1)  ·  Emergencies (1)  ·  Heart Arrest (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Tachycardia, Supraventricular (1)

Sponsors

Assiut University (1)  ·  Evan Adelstein, MD (1)  ·  Hospital Clinic of Barcelona (1)  ·  Hospital General Universitario Gregorio Marañon (1)  ·  Jeffrey Moak (1)  ·  Mayo Clinic (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  Ottawa Hospital Research Institute (1)  ·  University of British Columbia (1)  ·  University of Utah (1)  ·  University of Washington (1)  ·  Vanderbilt University Medical Center (1)

Countries

Canada (4)  ·  United States (3)  ·  Spain (2)

Top investigators

H. Greene (2)  ·  Blanca Coll-Vinent, MD (1)  ·  Carmen del Arco, MD (1)  ·  Dawood Darbar, MD, PhD (1)  ·  Dolores Vigil, MD (1)  ·  Evan Adelstein, MD (1)  ·  Fernando Arribas, MD (1)  ·  Frank Scheuermeyer, MD (1)  ·  Girish Nair, MD (1)  ·  Ian G Stiell, MD, MSc (1)  ·  Jeffrey Moak (1)  ·  Mercedes Ortiz, PhD (1)  ·  Rafael Peinado, MD (1)

Results publications

PMID 1377359, PMID 16403928, PMID 1900101, PMID 19917887, PMID 22032709, PMID 22082198, PMID 28974568, PMID 41218981, PMID 9078197, PMID 9078198

NIH funding

2005 (1), R01HL031472 (1), R01HL034071 (1), U19HL065962 (1)